News

What health research can I trust?

Resources
A free online course which helps participants judge how reliable health research is.

Cutting edge medicines for the patients who need them most

Policy
On 7 March 2016, the European Medicines Agency (EMA) launched PRIME : Priority Medicines. PRIME is a new scheme that will provide scientific and regulatory support to researchers and medicine developers with the aim of benefitting patients without treatment options or “unmet medical needs”.

Less than a month to Congress

Events
With less than a month to go until Congress, the IAPO office is a hive of activity! Registrations have doubled in the last month and we can't wait to see you there. The event promises to be an exciting time. You'll meet with patients' representatives, health professionals and experts from across the globe. Don't miss out!

One month to go: your to-do list for Congress

Events
There is one month to go until the 7th Global Patients Congress begins!

Speaker biographies for Congress

Events
Speaker biographies for the 7th Global Patients Congress are now available.

Learning resources to help you do more

Resources
Over the course of 2016, IAPO will be looking at what e-learning resources are currently available and how we can help fill the gaps.

Acting early to prevent kidney disease - World Kidney Day 2016

Members
10 March 2016 will see the eleventh World Kidney Day take place. This year’s theme is ‘Kidney Disease & Children. Act Early to Prevent It!’ The day will focus on improving education, facilitating early detection and ensuring that throughout an individual’s life – starting at birth – everyone is well equipped to combat and manage kidney disease.

We thank two long-standing Board members

Other
We would like to thank both KP Tsang and Eva Maria Ruiz de Castilla, who have left the IAPO Governing Board after many years of service.

Biosimilar medicines still a pressing issue for patients worldwide

Members
From 4-6 February 2016, EFCCA (the European Crohn´s and Ulcerative Colitis Associations) together with GAfPA (Global Alliance for Patient Access), organised an advocacy workshop on patient safety in Barcelona that gathered over 60 patient representatives from a wide range of immune modulate disease groups and other organizations .

WHO renews official relations status with IAPO

Partnerships
We are very pleased to announce that IAPO’s official relations status with the World Health Organization has been renewed.

Pages